DCCR Tablets for GSD1A Granted Orphan Drug Status
https://unsplash.com/photos/8ztH-7lj8ag

DCCR Tablets for GSD1A Granted Orphan Drug Status

In a news release from June 2, 2021, biopharmaceutical company Soleno Therapeutics, Inc. ("Soleno") shared an exciting update. The company's investigational treatment, DCCR (diazoxide choline) Extended-Release tablets, received Orphan Drug…

Continue Reading DCCR Tablets for GSD1A Granted Orphan Drug Status